Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage

Journal of Diabetes and its Complications

Volumn 22, Issue 1, 2008, Pages 46-55

  Guo, Zhiyong ^a   Bu, Shizhong ^b   Yu, Yongwei ^a   Ghatnekar, Gautam ^c   Wang, Minjie ^a   Chen, Lei ^d   Bu, Min ^c   Yang, Linhui ^a   Zhu, Binggen ^b   Feng, Zhengkang ^a   Huang, Qin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Abdominal adiposity; Diazoxide; Fatty liver; OLETF rats; Prevention

Indexed keywords

DIAZOXIDE; FAT; FATTY ACID; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG EFFECT; DRUG INHIBITION; FATTY ACID BLOOD LEVEL; FATTY LIVER; FOOD INTAKE; HISTOPATHOLOGY; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LIPID METABOLISM; LIPID STORAGE; LIVER; MALE; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WORKLOAD;

ABDOMINAL FAT; ANIMALS; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; DIAZOXIDE; DISEASE MODELS, ANIMAL; EATING; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LIPIDS; LIVER; MALE; OBESITY; PANCREAS; PREDIABETIC STATE; RATS; RATS, INBRED OLETF;

EID: 37749020578     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.08.005     Document Type: Article

References (52)

1. Aizawa T., Taguchi N., Sato Y., Nakabayashi T., Kobuchi H., Hidaka H., et al. Prophylaxis of genetically determined diabetes by diazoxide: A study in a rat model of naturally occurring obese diabetes. Journal of Pharmacology and Experimental Therapeutics 275 (1995) 194-199
2. Alba L.M., and Lindor K. Review article: Non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 17 (2003) 977-986
3. +-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats. Metabolism 53 (2004) 441-447
4. Alemzadeh R., and Holshouser S. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats. Endocrinology 140 (1990) 3197-3202
5. Alemzadeh R., and Jacobs W. Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 45 (1996) 334-341
6. Alemzadeh R., Langley G., Upchurch L., Smith P., and Slonim A.E. Beneficial effect of diazoxide in obese hyperinsulinemic adults. Journal of Clinical Endocrinology and Metabolism 83 (1998) 1911-1915
7. Alemzadeh R., Slonim A.E., Zdanowicz M.M., and Maturo J. Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133 (1993) 705-712
8. Alemzadeh R., and Tushaus K.M. Modulation of adipoinsular axis in prediabetic Zucker diabetic fatty rats by diazoxide. Endocrinology 145 (2004) 5476-5484
9. Arad Y., Newstein D., Cadet F., Roth M., and Guerci A.D. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arteriosclerosis, Thrombosis, and Vascular Biology 21 (2001) 2051-2058
10. Avenell, A., Broom, J., Brown, T. J., Poobalan, A., Aucott, L., Stearns, S. C., et al. (2004). Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technology Assessment 8:iii-iv, 1-182.
11. Bellentani S., Saccoccio G., Masutti F., Croce L.S., Brandi G., Sasso F., et al. Prevalence and risk factors for hepatic steatosis in Northern Italy. Annals of Internal Medicine 132 (2000) 112-117
12. Brown A.S. Lipid management in patients with diabetes mellitus. American Journal of Cardiology 96 (2005) 26-32
13. Brunt E.M. Nonalcoholic steatohepatitis. Seminars in Liver Disease 24 (2004) 3-20
14. Carr R.D., Brand C.L., Bodvarsdottir T.B., Hansen J.B., and Sturis J. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rats. Diabetes 52 (2003) 2513-2518
15. Choudhury J., and Sanyal A.J. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clinics in Liver Disease 8 (2004) 575-594 (ix)
16. Choudhury J., and Sanyal A.J. Clinical aspects of fatty liver disease. Seminars in Liver Disease 24 (2004) 349-362
17. Day C., and James O. Steatohepatitis: A tale of two 'hits'?. Gastroenterology 114 (1998) 842-845
18. Fujimoto W.Y., Bergstrom R.W., Boyko E.J., Chen K.W., Leonetti D.L., Newell-Morris L., et al. Visceral adiposity and incident coronary heart disease in Japanese-Am men: The 10-year follow-up results of the Seattle Japanese-Am Community Diabetes Study. Diabetes Care 22 (1999) 1808-1812
19. Guldstrand M., Grill V., Bjorklund A., Lins P.E., and Adamson U. Improved β-cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. Diabetes and Metabolism 28 (2002) 448-456
20. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Diabetes 41 (1992) 1422-1428
21. Kuriyama H., and Matsuzawa Y. Molecular mechanism of hyperlipidemia in the OLETF rat. In: Shima K. (Ed). Obesity and NIDDM lessons from the OLETF rat (1999), Elsevier, New York 149-157
22. Laakso M., and Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137 (1998) S65-S73
23. Le Stunff C., and Bougneres P. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43 (1994) 696-702
24. Lin J.D., Chiou W.K., Weng H.F., Fang J.T., and Liu T.H. Application of three-dimensional body scanner: Observation of prevalence of metabolic syndrome. Clinical Nutrition 23 (2004) 1313-1323
25. Lopez S., and Desbuquois B. Insulin-related changes in the subcellular distribution of insulin receptors in intact rat liver: Effects of acute hypoinsulinemia induced by diazoxide, somatostatin, and xylazine. Endocrinology 120 (1987) 1695-1702
26. Luyckx F.H., Desaive C., Thiry A., Dewe W., Scheen A.J., Gielen J.E., et al. Liver abnormalities in severely obese subjects: Effects of drastic weight loss after gastroplasty. International Journal of Obesity and Related Metabolic Disorders 22 (1998) 222-226
27. Man Z.W., Hirashima T., Mori S., and Kawano K. Decrease in triglyceride accumulation in tissues by restricted diet and improvement of diabetes in Otsuka Long-Evans Tokushima Fatty rats, a non-insulin dependent diabetes model. Metabolism 49 (2000) 108-114
28. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
29. Mori Y., Hoshino K., Yokota K., Yokose T., and Tajima N. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Experimental and Clinical Endocrinology and Diabetes 113 (2005) 334-339
30. Nolte L.A., Galuska D., Martin I.K., Zierath J.R., and Wallberg-Henriksson H. Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. Acta Physiologica Scandinavica 151 (1994) 51-59
31. Pospisilik J.A., Stafford S.G., Demuth H.U., McIntosh C.H., and Pederson R.A. Long-term treatment with dipeptidyl peptidase IV inhibitor improved hepatic and peripheral insulin sensitivity in the VDF rat: A euglycemic-hyperinsulinemic clamp study. Diabetes 51 (2002) 2677-2683
32. Powell E.E., Jonsson J.R., and Clouston A.D. Steatosis: Co-factor in other liver diseases. Hepatology 42 (2005) 5-13
33. Rashid M., and Roberts E. Nonalcoholic steatohepatitis in children. Journal of Pediatric Gastroenterology and Nutrition 30 (2000) 48-53
34. Roberts E.A. Non-alcoholic fatty liver disease (NAFLD) in children. Frontiers in Bioscience 10 (2005) 2306-2318
35. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., et al. Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 97 (1996) 2859-2865
36. Ross R., Leger L., Guardo R., De Guise J., and Pike B.G. Adipose tissue volume measured by magnetic resonance imaging and computerized tomography in rats. Journal of Applied Physiology 70 (1991) 2164-2172
37. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
38. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
39. Sato T., Magata K., Koga N., and Mitsumoto Y. Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model. Biochemical and Biophysical Research Communications 245 (1998) 378-381
40. Sato T., Man Z.W., Toide K., and Asahi Y. Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of NIDDM. FEBS Letters 407 (1997) 329-332
41. Seufert J., Kieffer T.J., Leech C.A., Holz G.G., Moritz W., Ricordi C., et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implication for the development of adipogenic diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 84 (1999) 670-676
42. Shimabukuro M., Higa M., Zhou Y.T., Wang M.Y., Newgard C.B., and Unger R.H. Lipoapoptosis in the β-cells of obese prediabetic fa/fa rats: Role of serine palmitoyltransferase overexpression. Journal of Biological Chemistry 49 (1998) 32487-32490
43. Spiegelman B.M., and Flier J.S. Adipogenesis and obesity: Rounding out the big picture. Cell 87 (1996) 377-389
44. Standridge M., Alemzadeh R., Koontz J., and Moustaid N. Diazoxide downregulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB Journal 14 (2000) 455-460
45. Tayama K., Inukai T., and Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 43 (1999) 49-58
46. Toide K., Man Z.W., Asahi Y., Sato T., Nakayama N., Noma Y., et al. Glucose transporter levels in a male spontaneous NIDDM rat of Otsuka Long-Evans Tokushima Fatty strain. Diabetes Research and Clinical Practice 38 (1997) 151-160
47. Twombly R. The big fat question: What is the role of excess weight in cancer risk, mortality?. Journal of the National Cancer Institute 97 (2005) 1110-1112
48. Wang Y., Rimm E.B., Stampfer M.J., Willett W.C., and Hu F.B. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. American Journal of Clinical Nutrition 81 (2005) 555-563
49. Wigand J.P., and Blackard W.G. Downregulation of insulin receptors in obese man. Diabetes 28 (1979) 287-291
50. Yamamoto M., Jia D.M., Fukumitsu K., Imoto I., Kihara Y., Hirohata Y., et al. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by α-glucosidase inhibitor. Metabolism 48 (1999) 347-354
51. Yamashita S., Nakamura T., Shimomura I., Nishida I., Yoshida Y., Kotani Y., et al. Insulin resistance and body fat distribution. Diabetes Care 19 (1996) 287-291
52. Zimmet P., Boyko E.J., Collier G.R., and de Courten M. Etiology of the metabolic syndrome: Potential role of insulin resistance, leptin resistance, and other players. Annals of the New York Academy of Sciences 892 (1999) 25-44